 GAVIN
|
Gador
|
| pregabalina |
Antiepiléptico |
| 150 mg cáps.x 28 | $46.668,31 | (30/08/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $23.334,15 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $27.903,21 AF $18.765,10 |
|
|
|
|
| 150 mg cáps.x 30 | $52.764,57 | (29/04/25) |
| PAMI |
|
| AF $24.652,01 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $27.989,52 AF $24.775,05 |
|
|
|
|
| 25 mg cáps.x 28 | $10.221,16 | (30/08/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $4.700,89 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $7.206,03 AF $3.015,13 |
|
|
|
|
| 25 mg cáps.x 30 | $11.283,87 | (29/04/25) |
| PAMI |
|
| AF $4.909,57 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $7.262,08 AF $4.021,79 |
|
|
|
|
| 300 mg cáps.x 28 | $64.223,31 | (16/07/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $32.111,65 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $42.426,32 AF $21.796,99 |
|
|
|
|
| 300 mg cáps.x 30 | $68.705,54 | (29/04/25) |
| PAMI |
|
| AF $33.318,96 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $41.488,21 AF $27.217,33 |
|
|
|
|
| 50 mg cáps.x 28 | $20.910,03 | (30/08/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $9.493,82 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $16.192,02 AF $4.718,01 |
|
|
|
|
| 50 mg cáps.x 30 | $24.354,23 | (29/04/25) |
| PAMI |
|
| AF $10.943,06 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $15.449,24 AF $8.904,99 |
|
|
|
|
| 75 mg cáps.x 28 | $27.048,93 | (16/07/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $13.524,47 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $18.452,49 AF $8.596,44 |
|
|
|
|
| 75 mg cáps.x 30 | $31.347,74 | (29/04/25) |
| PAMI |
|
| AF $15.175,66 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $19.932,47 AF $11.415,27 |
|
|
|
|
| |
